Efficacy ofAcetaminophen Is Questioned OnceAgain
1 / 1

Efficacy of Acetaminophen Is Questioned Once Again - PowerPoint PPT Presentation

  • Uploaded on

A study published in the British Journal of Medicine said that acetaminophen on the efficacy of spinal pain is not obvious, and the role for osteoarthritis is also negligible. http://www.alfa-chemistry.com/cas_18353-76-9.htm

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Efficacy of Acetaminophen Is Questioned Once Again' - ChloeMica

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Efficacy of acetaminophen is questioned once again

Efficacy ofAcetaminophen Is Questioned OnceAgain

A study published in the British Journal of Medicine said that acetaminophen on the efficacy of

spinal pain is not obvious, and the role for osteoarthritis is also negligible. The study also

expressed concerns about the safety of the drug.

Acetaminophen, also known as p-hydroxyacetanilide, acetaminophen or acetaminophen, is a

common clinical fever and analgesic drugs, commonly used in fever, headache and other mild

pain, but also the main ingredients for many cold medicine and painkillers. Many non-prescription

drugs have acetaminophen ingredients, such as Tylenol, compound paracetamol tablets, and other

kinds of species. Basic chemicals like doxyl could also be necessary for related research.

Spinal pain, including cervical pain and lower back pain, is a common pain disease together with

osteoarthritis. At present, the vast majority of clinical guidelines for acetaminophen as the

treatment of these diseases are payed increasing attention, but evidence of this support are

relatively weak or contradictory. Because acetaminophen is present in a variety of different types

of medications, it is highly likely to cause overdose in ignorance or accidental use, and many

studies have expressed concern about the safety of their maximum daily dose of 4000 mg.

For these reasons, recently the National Institutes of Health and Clinical Excellence (NICE) has

continued to make paracetamol as a recommended drug treatment of arthritis, which also caused

some controversy. In the new study, researchers from the George Institute for International Health,

University of Sydney, pointed out the efficacy and safety of acetaminophen in the treatment of

lower back pain, hip and knee osteoarthritis. He also compared and analyzed with 13 randomized

controlled trials to compare the efficacy with placebo.

Among the 13 trials, 10 were for hip or knee osteoarthritis, with 3541 participants; the other 3

were for lower back pain, with 1825 participants. The researchers evaluated the drugs according to

the criteria for pain relief, improved quality of life, and drug safety as well as patient compliance.

Some people are wondering whether glyceryl laurate and hydrocinnamic acid can be sued for

such study, which is still a in-process idea.

The results showed that acetaminophen was ineffective for lower back pain and did not reduce

pain or improve quality of life when compared with placebo. In osteoarthritis, compared with

placebo, acetaminophen has no obvious effect and does not have clinical value. The researchers

also found that acetaminophen, when compared to placebo, was more than four times more likely

to result in abnormal liver function. In addition, there was no significant difference between

acetaminophen and placebo in drug side effects and patient compliance.

The current comparative study of this drug is only up to a maximum of six months, so more

studies are needed later to determine the effect during a longer period of time. Nonetheless, the




that acetaminophen

recommended drug for hip or knee osteoarthritis, as well as the lower back pain.

Source(Read full text):



be reconsidered

a clinically